Kathleen M Sturgeon1, Renata Hackley2, Anna Fornash2, Lorraine T Dean3, Monica Laudermilk4, Justin C Brown5, David B Sarwer6, Angela M DeMichele2, Andrea B Troxel7, Kathryn H Schmitz1. 1. Department of Public Health Sciences, Pennsylvania State University, Hershey, Pennsylvania. 2. Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania. 3. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 4. EXOS, Phoenix, Arizona. 5. Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts. 6. College of Public Health, Temple University, Philadelphia, Pennsylvania. 7. Department of Population Health, New York University, New York City, New York.
Abstract
BACKGROUND:Black women are more likely to experience adverse effects from cancer treatment such as lymphedema. Thus, black women may particularly benefit from research regarding interventions to improve lymphedema. Herein, the authors report the challenges and strategies related to the recruitment of minority survivors of breast cancer and to the recruitment of survivors of breast cancer with lymphedema into the Women In Steady Exercise Research (WISER) Survivor Clinical Trial. METHODS:Subjects for this community-based trial were recruited from the Philadelphia area through active (mailings) and passive (printed materials and Web site) recruitment strategies. In addition, education sessions coordinated through partner hospitals in communities with a predominantly minority population were conducted to increase awareness of lymphedema in survivors of breast cancer. Women who were interested in the study were screened for lymphedema via telephone questionnaire and invited to see a study-related certified lymphedema therapist to confirm the presence of lymphedema. RESULTS: Screening was conducted among 2295 women: 628 were eligible, 450 consented, and 351 were randomized. Minority women comprised 38% of the study population. Letters to women on state and hospital registries resulted in a 0.4% randomization rate; education sessions yielded a 10% randomization rate. The authors observed that approximately 23.6% of the study sample had no previous diagnosis of lymphedema. CONCLUSIONS: The WISER Survivor Clinical Trial faced multiple recruitment challenges and used unique strategies to successfully enroll minority survivors of breast cancer into a lifestyle intervention. Cancer 2018;124:95-104.
RCT Entities:
BACKGROUND: Black women are more likely to experience adverse effects from cancer treatment such as lymphedema. Thus, black women may particularly benefit from research regarding interventions to improve lymphedema. Herein, the authors report the challenges and strategies related to the recruitment of minority survivors of breast cancer and to the recruitment of survivors of breast cancer with lymphedema into the Women In Steady Exercise Research (WISER) Survivor Clinical Trial. METHODS: Subjects for this community-based trial were recruited from the Philadelphia area through active (mailings) and passive (printed materials and Web site) recruitment strategies. In addition, education sessions coordinated through partner hospitals in communities with a predominantly minority population were conducted to increase awareness of lymphedema in survivors of breast cancer. Women who were interested in the study were screened for lymphedema via telephone questionnaire and invited to see a study-related certified lymphedema therapist to confirm the presence of lymphedema. RESULTS: Screening was conducted among 2295 women: 628 were eligible, 450 consented, and 351 were randomized. Minority women comprised 38% of the study population. Letters to women on state and hospital registries resulted in a 0.4% randomization rate; education sessions yielded a 10% randomization rate. The authors observed that approximately 23.6% of the study sample had no previous diagnosis of lymphedema. CONCLUSIONS: The WISER Survivor Clinical Trial faced multiple recruitment challenges and used unique strategies to successfully enroll minority survivors of breast cancer into a lifestyle intervention. Cancer 2018;124:95-104.
Authors: Marilyn L Kwan; Jeanne Darbinian; Kathryn H Schmitz; Rebecca Citron; Paula Partee; Susan E Kutner; Lawrence H Kushi Journal: Arch Surg Date: 2010-11
Authors: Marilyn L Kwan; Ling Shen; Julie R Munneke; Emily K Tam; Paula N Partee; Mary André; Susan E Kutner; Carol P Somkin; Lynn M Ackerson; Saskia R J Thiadens Journal: Breast Cancer Res Treat Date: 2012-08-19 Impact factor: 4.872
Authors: Sam S Oh; Joshua Galanter; Neeta Thakur; Maria Pino-Yanes; Nicolas E Barcelo; Marquitta J White; Danielle M de Bruin; Ruth M Greenblatt; Kirsten Bibbins-Domingo; Alan H B Wu; Luisa N Borrell; Chris Gunter; Neil R Powe; Esteban G Burchard Journal: PLoS Med Date: 2015-12-15 Impact factor: 11.069
Authors: Justin C Brown; Kathleen Sturgeon; David B Sarwer; Andrea B Troxel; Angela M DeMichele; Crystal S Denlinger; Kathryn H Schmitz Journal: Endocr Relat Cancer Date: 2022-06-29 Impact factor: 5.900
Authors: Justin C Brown; David B Sarwer; Andrea B Troxel; Kathleen Sturgeon; Angela M DeMichele; Crystal S Denlinger; Kathryn H Schmitz Journal: Breast Cancer Res Treat Date: 2021-06-05 Impact factor: 4.624
Authors: Justin C Brown; David B Sarwer; Andrea B Troxel; Kathleen Sturgeon; Angela M DeMichele; Crystal S Denlinger; Kathryn H Schmitz Journal: Cancer Date: 2021-06-23 Impact factor: 6.921
Authors: Carmina G Valle; Lindsey N Camp; Molly Diamond; Brooke T Nezami; Jessica Gokee LaRose; Bernardine M Pinto; Deborah F Tate Journal: Trials Date: 2022-04-04 Impact factor: 2.728